1. AB0194 Peripheral Blood Perfusion as Evaluated by Laser Speckle Contrast Analysis in Different Areas of Hands in Primary Raynaud's Phenomenon and Healthy Subjects. (9th June 2015) Authors: Sulli, A.; Ruaro, B.; Smith, V.; Pizzorni, C.; Ravera, F.; Cariti, C.; Cutolo, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 956 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeks. (17th November 2022) Authors: Mastorino, Luca; Cariti, C.; Susca, S.; Boskovic, S.; Aquino, C.; Ortoncelli, M.; Stroppiana, E.; Verrone, A.; Dapavo, P.; Quaglino, P.; Ribero, Simone Journal: Journal of dermatological treatment Issue: Volume 33:Number 8(2022) Page Start: 3211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparison of Secukinumab and Ixekizumab in psoriasis: a real‐life cohort study on the efficacy and drug survival of 445 patients. (7th November 2021) Authors: Cariti, C.; Dapavo, P.; Mastorino, L.; Ortoncelli, M.; Siliquini, N.; Merli, M.; Avallone, G.; Giordano, S.; Fabrizio, R.; Susca, S.; Verrone, A.; Stroppiana, E.; Quaglino, P.; Ribero, S. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 3(2022) Page Start: e233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0449 Presence of Abnormal Capillary Dilations in Primary Raynaud Phenomenon Subjects Might Anticipate the Transition to the Capillaroscopic "Early" Scleroderma Pattern: A Case Control Study. (9th June 2015) Authors: Trombetta, A.C.; Sulli, A.; Pizzorni, C.; Meroni, M.; Cariti, C.; Paolino, S.; Ruaro, B.; Cutolo, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 590 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Real‐life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis. (24th March 2022) Authors: Avallone, G.; Cariti, C.; Dapavo, P.; Ortoncelli, M.; Conforto, L.; Mastorino, L.; Roccuzzo, G.; Cavallo, F.; Rubatto, M.; Quaglino, P.; Ribero, S. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 7(2022) Page Start: e574 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Risankizumab shows faster response in bio naïve than in bio‐experienced psoriatic patients. (22nd June 2022) Authors: Mastorino, L.; Castelli, F.; Stroppiana, E.; Verrone, A.; Ortoncelli, M.; Susca, S.; Boskovic, S.; Passerini, S.G.; Macagno, N.; Cariti, C.; Licciardello, M.; Solaroli, C.; Pertusi, G.; Aragone, M.G.; Baggini, G.; Addese, C.; Leporati, C.; Peila, R.; Giura, M.T.; Rossotto, G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 10(2022) Page Start: e838 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗